Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4785 (MIR4785) is purported to be a human microRNA, a small (~22 nucleotide) non-coding RNA involved in post-transcriptional regulation of gene expression, typically by binding to complementary sequences in target messenger RNAs to inhibit their translation or promote their degradation[2][3][4]. However, there is insufficient evidence in publicly available databases or peer-reviewed literature to confirm the existence, sequence, or disease relevance of mir-4785 specifically. Unlike established microRNA family members, "MIR4785" does not appear in major microRNA databases (e.g., miRBase) or authoritative functional genomics resources, suggesting that it may be misspelled, unvalidated, or not widely recognized as a functional molecular target. Therefore, it should not be considered an established therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4785 (MIR4785).